TsalikianE, FoxL, WeinzimerS, BuckinghamB, WhiteNH, BeckR, KollmanC, XingD, RuedyK. Diabetes Research in Children Network (DirecNet) Study Group. Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes. Pediatr Diabetes, 2012; 13:301–7.
2.
BattelinoT, PhillipM, BratinaN, NimriR, OskarssonP, BolinderJ.Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care, 2011; 34:795–800.
3.
MaurasN, BeckR, XingD, RuedyK, BuckinghamB, TanseyM, WhiteNH, WeinzimerSA, TamborlaneW, KollmanC. Diabetes Research in Children Network (DirecNet) Study Group. A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years. Diabetes Care, 2012; 35:204–10.
4.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. TamborlaneWV, BeckRW, BodeBW, BuckinghamB, ChaseHP, ClemonsR, Fiallo-ScharerR, FoxLA, GilliamLK, HirschIB, HuangES, KollmanC, KowalskiAJ, LaffelL, LawrenceJM, LeeJ, MaurasN, O'GradyM, RuedyKJ, TanseyM, TsalikianE, WeinzimerS, WilsonDM, WolpertH, WysockiT, XingD.Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med, 2008; 359:1464–76.
5.
PhillipM, DanneT, ShalitinS, BuckinghamB, LaffelL, TamborlaneW, BattelinoT. Consensus Forum Participants. Use of continuous glucose monitoring in children and adolescents. Pediatr Diabetes, 2012; 13:215–28.
6.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. BeckRW, BuckinghamB, MillerK, WolpertH, XingD, BlockJM, ChaseHP, HirschI, KollmanC, LaffelL, LawrenceJM, MilaszewskiK, RuedyKJ, TamborlaneWV. Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care, 2009; 32:1947–53.
7.
PickupJC, FreemanSC, SuttonAJ.Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ, 2011; 343:d3805.
8.
Ludwig-SeiboldCU, HolderM, RamiB, RaileK, HeidtmannB, HollRW. DPV Science Initiative, German Working Group for insulin pump treatment in pediatric patients, German BMBF Competence Network Diabetes. Continuous glucose monitoring in children, adolescents, and adults with type 1 diabetes mellitus: analysis from the prospective DPV diabetes documentation and quality management system from Germany and Austria. Pediatr Diabetes, 2012; 13:12–4.
9.
KordonouriO, HartmannR, PankowskaE, RamiB, KapellenT, CoutantR, LangeK, DanneT. Sensor augmented pump therapy from onset of type 1 diabetes: late follow-up results of the Pediatric Onset Study. Pediatr Diabetes, 2012Apr 5;13:515–8. 10.1111/j.1399-5448.2012.00863.x.
10.
PozzilliP, SchlootNC, HosszufalusiNet al.Time dependent C-peptide decline in 4411 patients with recent onset type 1 diabetes followed for up to 10 yrs: a meta-analysis from 8 European centres. Diabetologia, 2011; 54,Suppl. 1:S74.
11.
GargS, BrazgRL, BaileyTS, BuckinghamBA, SloverRH, KlonoffDC, ShinJ, WelshJB, KaufmanFR.Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study. Diabetes Technol Ther, 2012; 14:205–9.
12.
RivelineJP, SchaepelynckP, ChaillousL, RenardE, Sola-GazagnesA, PenfornisA, Tubiana-RufiN, SulmontV, CatargiB, LukasC, RadermeckerRP, ThivoletC, MoreauF, BenhamouPY, GuerciB, LeguerrierAM, MillotL, SachonC, CharpentierG, HanaireH. EVADIAC Sensor Study Group. Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year multicenter study. Diabetes Care, 2012; 35:965–71.
13.
YardleyJE, KennyGP, PerkinsBA, RiddellMC, MalcolmJ, BoulayP, KhandwalaF, SigalRJ.Effects of performing resistance exercise before versus after aerobic exercise on glycemia in type 1 diabetes. Diabetes Care, 2012; 35:669–75.
14.
VigerskyRA, FondaSJ, ChellappaM, WalkerMS, EhrhardtNM.Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes. Diabetes Care, 2012; 35:32–8.
15.
CastaldoE, SabatoD, LauroD, SestiG, MariniMA.Hypoglycemia assessed by continuous glucose monitoring is associated with preclinical atherosclerosis in individuals with impaired glucose tolerance. PLoS One, 2011; 6:e28312.
16.
KlonoffDC, BuckinghamB, ChristiansenJS, MontoriVM, TamborlaneWV, VigerskyRA, WolpertH. Endocrine Society. Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 2011; 96:2968–79.
17.
GandhiGY, KovalaskeM, KudvaY, WalshK, ElaminMB, BeersM, CoyleC, GoalenM, MuradMS, ErwinPJ, CorpusJ, MontoriVM, MuradMH.Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trials. J Diabetes Sci Technol, 2011; 5:952–65.
18.
SzypowskaA, RamotowskaA, DzygaloK, GolickiD.Beneficial effect of real-time continuous glucose monitoring system on glycemic control in type 1 diabetic patients: systematic review and meta-analysis of randomized trials. Eur J Endocrinol, 2012; 166:567–74.
19.
LangendamM, LuijfYM, HooftL, DevriesJH, MuddeAH, ScholtenRJ.Continuous glucose monitoring systems for type 1 diabetes mellitus. Cochrane Database Syst Rev, 2012; 1CD008101.
20.
YehHC, BrownTT, MaruthurN, RanasingheP, BergerZ, SuhYD, WilsonLM, HaberlEB, BrickJ, BassEB, GoldenSH.Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann Intern Med, 2012: E-508; Sept 4;157,5:336–47. 10.7326/0003-4819-157-5-201209040-00508.
